United States Temporary Artificial Heart Replacement Devices Market Report 2018

SynCardia's CardioWest was the world's first FDA-approved total artificial heart. It received FDA approval in October 2004 following a ten-year pivotal clinical study. The CardioWest was originally designed as a permanent replacement heart, but was approved as a bridge-to-transplant device for patients dying due to irreversible end-stage biventricular failure in which both the left and right ventricles of their hearts are failing. SynCardia's CardioWest is now marketed as the SynCardia Total Artificial Heart. As of 2017, SynCardia's Total Artificial Heart has been implanted in over 1,700 cases worldwide, with over 500 implants in the United States. It is estimated to have accounted for more than 600 patient years of extended life on the device.Key Topics Covered:Executive Summary

SynCardia's CardioWest was the world's first FDA-approved total artificial heart. It received FDA approval in October 2004 following a ten-year pivotal clinical study.

The CardioWest was originally designed as a permanent replacement heart, but was approved as a bridge-to-transplant device for patients dying due to irreversible end-stage biventricular failure in which both the left and right ventricles of their hearts are failing. SynCardia's CardioWest is now marketed as the SynCardia Total Artificial Heart.

As of 2017, SynCardia's Total Artificial Heart has been implanted in over 1,700 cases worldwide, with over 500 implants in the United States. It is estimated to have accounted for more than 600 patient years of extended life on the device.

Key Topics Covered:

Executive Summary

1. Research Methodology

2. Disease Overview

3. Product Portfolio

4. Temporary Artificial Heart Replacement Device Market

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/3wdpt9/united_states?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716